Page 9 - Lobe Sciences News Today

  The industry is projected to reach a TOTAL VALUE OF US$7B by 2027. Grab your FREE report so you dont miss out on the shroom boom! (As a BONUS, you’ll also get our free psychedelics investing newsletter and investor kits with email updates from curated companies below!*). Enter your email below for instant access: Include me in the Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not dep...

triple-digit returns in the last year Optimism is brewing as governments grant research approvals for the study of psychedelics on mental health By some estimates, the psychedelic drugs market is projected to see compound annual growth (CAGR) of  16.3% to reach  Psyched About Psychedelics Psychedelic stocks are trading like biotechnology companies these days. The prospect of promising research has pushed valuations upwards. And like biotech companies, they often report no revenues and are a...

Lobe Sciences Ltd.: Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement Lobe" or the " Company"), is pleased to announce that it has upsized its previously announced non-brokered private placement of units (the " Units") from $2,000,000 to up to $2,700,000 (the " Offering") and has completed a first closing raising gross proceeds of $2,327,100 (the " First Tranche Closing"). The First Tranche Closing consisted of the issuance of an aggregate of 23,271,000 Units...

Lobe Sciences Ltd.: Lobe Sciences Announces Non-Brokered Private Placement Lobe" or the " Company") is pleased to announce that it intends to raise up to Cdn$2,000,000 (the " Offering") through a non-brokered private placement of up to 20,000,000 units (the " Units") at a price of Cdn$0.10 per Unit. Each Unit will consist of one common share in the capital of the Company (each a " Share") and one share purchase warrant (each a " Warrant"). Each Warrant will entitle the subscriber to acquire on...